On this page
Evidence dossier
The report behind the claim
The investigators reported attenuation of induced retinal injury in treated animals. A drug-induced retinal model does not establish treatment of human retinal disease or a safe ocular product.
BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Rats receiving a retrobulbar L-NAME challenge
- Endpoint
- Retinal vessels, pressure, behavior and histology over four weeks
- Finding on record
- The investigators reported attenuation of induced retinal injury in treated animals.
- Limits of inference
- A drug-induced retinal model does not establish treatment of human retinal disease or a safe ocular product.
The experiment in view
The study used rats receiving a retrobulbar L-NAME challenge. Its principal measures were retinal vessels, pressure, behavior and histology over four weeks. The investigators reported attenuation of induced retinal injury in treated animals.
Reading the result closely
The initiating chemical challenge and the route of administration constrain interpretation. Preserved retinal thickness and behavioral observations should not be relabeled as restored vision in patients. A formulation intended for one tissue cannot be substituted for an eye preparation because the ingredient name matches.
The boundary of the finding
A drug-induced retinal model does not establish treatment of human retinal disease or a safe ocular product.
Related evidence, kept separate
BPC-157 and pharmacologically altered pupil size examines pupil diameter and time course of drug responses. Here, the measured endpoint was retinal vessels, pressure, behavior and histology over four weeks. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the BPC-157 and corneal anesthesia: shorter numbing is not better human eye care appraisal.
On the record
The documents supporting this report.